Moderna, Merck's Groundbreaking Melanoma Treatment Shows Promise in Combination Therapy Study The collaborative effort harnesses Merck's expertise in immuno-oncology and Moderna's innovative mRNA technology to make a meaningful impact on patient outcomes. by Inno Flores